본문으로 건너뛰기
← 뒤로

Gamma knife radiosurgery vs fractionated radiotherapy : gender difference in efficacy and toxicity.

1/5 보강
Pituitary 2026 Vol.29(1) p. 41
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
Gamma knife radiosurgery
C · Comparison 대조 / 비교
fractionated radiotherapy
O · Outcome 결과 / 결론
Endocrine efficacy in functioning pituitary adenomas and tumor control in nonfunctioning pituitary adenomas seem equivalent regardless of the technique. This review will try to determine whether gender should also be considered as a predictive factor of efficacy and toxicity.

Piazzola C, Graillon T, Sahakian N, Dufour H, Regis J, Brue T, Castinetti F

📝 환자 설명용 한 줄

Although radiation therapy is used less frequently in the treatment of functioning and nonfunctioning pituitary adenomas, it still plays a role to control volume and secretion.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Piazzola C, Graillon T, et al. (2026). Gamma knife radiosurgery vs fractionated radiotherapy : gender difference in efficacy and toxicity.. Pituitary, 29(1), 41. https://doi.org/10.1007/s11102-026-01643-3
MLA Piazzola C, et al.. "Gamma knife radiosurgery vs fractionated radiotherapy : gender difference in efficacy and toxicity.." Pituitary, vol. 29, no. 1, 2026, pp. 41.
PMID 41663864

Abstract

Although radiation therapy is used less frequently in the treatment of functioning and nonfunctioning pituitary adenomas, it still plays a role to control volume and secretion. Radiation therapy remains to be considered in the therapeutic algorithm for these diseases, as mentioned in all recent national and international guidelines. Recent studies have focused on the use of stereotactic approaches, either given as a single dose or as a fractionated one. However, some patients may still benefit from conformal fractionated radiotherapy. The choice among these procedures is currently based mainly on adenoma's profile in terms of size, quality of the radiological definition, invasiveness, and aggressiveness, as well as local availability. Endocrine efficacy in functioning pituitary adenomas and tumor control in nonfunctioning pituitary adenomas seem equivalent regardless of the technique. This review will try to determine whether gender should also be considered as a predictive factor of efficacy and toxicity.

MeSH Terms

Humans; Radiosurgery; Female; Pituitary Neoplasms; Male; Dose Fractionation, Radiation; Treatment Outcome; Adenoma; Sex Factors